Unlock the potential of adaptive immunity with ImmuneSelect by Virax Biolabs. Investigate T-Cell driven immunity for post-viral syndromes like Long COVID. Explore peptide pools and recombinant antibodies for immune profiling.
Thursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for…
LONDON - Virax Biolabs Group Limited , an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced a strategic collaboration.
Virax Biolabs Group Limited announced a strategic collaboration with the University of Manchester and the Northern Care Alliance Foundation Trust, who have a track record in working together to.
Virax Biolabs Group (VRAX) Enters Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.